Rheumatoid Arthritis: Novel Serologic Markers

Rheumatoid arthritis (RA), a chronic systemic autoimmune disease and the most common form of inflammatory polyarthritis, affects approximately 0.5% or 1.5 million people in the United States.¹ Without appropriate treatment, the persistent inflammation of RA causes a progressive erosive arthropathy that leads to severe joint damage, deformity and disability

References

1. Taylor PC. Update on the diagnosis and management of early rheumatoid arthritis. Clin Med (Lond). 2020
Nov;20(6):561-564.